دورية أكاديمية
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
العنوان: | Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial |
---|---|
المؤلفون: | Powles, Thomas, Kockx, Mark, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J., Van Der Heijden, Michiel S., Szabados, Bernadett, Pous, Albert Font, Gravis, Gwenaelle, Herranz, Urbano Anido, Protheroe, Andrew, Ravaud, Alain, Maillet, Denis, Mendez, Maria Jose, Suarez, Cristina, Linch, Mark, Prendergast, Aaron, van Dam, Pieter-Jan, Stanoeva, Diana, Daelemans, Sofie, Mariathasan, Sanjeev, Tea, Joy S., Mousa, Kelly, Banchereau, Romain, Castellano, Daniel |
المساهمون: | Roche, The CECM received additional core funding by the UK Experimental Cancer Medicine Network. Mr Jonathan Bull and Mr Michael Jacobson also provided financial support for aspects of the biomarker analysis |
المصدر: | Nature Medicine ; volume 26, issue 6, page 983-983 ; ISSN 1078-8956 1546-170X |
بيانات النشر: | Springer Science and Business Media LLC |
سنة النشر: | 2020 |
مصطلحات موضوعية: | General Biochemistry, Genetics and Molecular Biology, General Medicine |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1038/s41591-020-0923-3 |
الإتاحة: | https://doi.org/10.1038/s41591-020-0923-3Test http://www.nature.com/articles/s41591-020-0923-3.pdfTest http://www.nature.com/articles/s41591-020-0923-3Test |
حقوق: | https://www.springer.com/tdmTest ; https://www.springer.com/tdmTest |
رقم الانضمام: | edsbas.46168B17 |
قاعدة البيانات: | BASE |
DOI: | 10.1038/s41591-020-0923-3 |
---|